Literature DB >> 21091008

Corneal cross linking for keratoconus.

Anne Keating1, Roberto Pineda, Kathryn Colby.   

Abstract

Riboflavin-induced ultraviolet light (UV) cross linking has received a significant amount of attention in recent years. It is currently approved in Europe as a treatment for keratoconus and is also being used for other corneal disorders. The goal of this paper is to review in detail seminal papers and studies that have been done to support cross linking as a safe and effective treatment for patients with early stages of keratoconus.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 21091008     DOI： 10.3109/08820538.2010.518503

Source DB:  PubMed          Journal:  Semin Ophthalmol        ISSN： 0882-0538            Impact factor:   1.975


  7 in total

1.  Optical coherence tomography combined with videokeratography to differentiate mild keratoconus subtypes.

Authors:  Yaron S Rabinowitz; Xiaohui Li; Ana Laura Caiado Canedo; Renato Ambrósio; Yelena Bykhovskaya
Journal:  J Refract Surg       Date:  2014-02       Impact factor: 3.573

2.  Effect of the synthetic NC-1059 peptide on diffusion of riboflavin across an intact corneal epithelium.

Authors:  Yuntao Zhang; Pinakin Sukthankar; John M Tomich; Gary W Conrad
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-05-04       Impact factor: 4.799

Review 3.  Update on the Management of Infectious Keratitis.

Authors:  Ariana Austin; Tom Lietman; Jennifer Rose-Nussbaumer
Journal:  Ophthalmology       Date:  2017-09-21       Impact factor: 12.079

4.  Deep anterior lamellar keratoplasty in eyes previously treated with collagen crosslinking for keratoconus: 3-year results.

Authors:  Anıl Kubaloglu; Esin Sogutlu Sari; Arif Koytak
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2020-01-08       Impact factor: 3.117

5.  Attenuation of lysyl oxidase and collagen gene expression in keratoconus patient corneal epithelium corresponds to disease severity.

Authors:  Rohit Shetty; Arunapriya Sathyanarayanamoorthy; Reshma Airody Ramachandra; Vishal Arora; Anuprita Ghosh; Purnima Raman Srivatsa; Natasha Pahuja; Rudy M M A Nuijts; Abhijit Sinha-Roy; Rajiv R Mohan; Arkasubhra Ghosh
Journal:  Mol Vis       Date:  2015-01-12       Impact factor: 2.367

6.  Double-masked, sham and placebo-controlled trial of corneal cross-linking and topical difluprednate in the treatment of bacterial keratitis: Steroids and Cross-linking for Ulcer Treatment Trial (SCUT II) study protocol.

Authors:  Naveen Radhakrishnan; Venkatesh N Prajna; Lalitha S Prajna; Anitha Venugopal; Shivanandha Narayana; Revathi Rajaraman; Guillermo Amescua; Travis C Porco; Thomas M Lietman; Jennifer Rose-Nussbaumer
Journal:  BMJ Open Ophthalmol       Date:  2021-11-29

7.  Tissue-Derived Biological Particles Restore Cornea Properties in an Enzyme-Mediated Corneal Ectatic Model.

Authors:  Hongbo Yin; Xiaokun Wang; Shoumyo Majumdar; Jeeyeon Sohn; Byung-Jin Kim; Walter Stark; Jennifer H Elisseeff
Journal:  Bioengineering (Basel)       Date:  2019-09-27
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.